Back to Search
Start Over
Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling.
- Source :
-
Cytotherapy [Cytotherapy] 2022 Dec; Vol. 24 (12), pp. 1201-1210. Date of Electronic Publication: 2022 Sep 13. - Publication Year :
- 2022
-
Abstract
- Background Aims: Stem and progenitor cells of hematopoietic and mesenchymal lineages reside in the bone marrow under low oxygen (O <subscript>2</subscript> ) saturation. O <subscript>2</subscript> levels used in ex vivo expansion of multipotent mesenchymal stromal cells (MSCs) affect proliferation, metabolism and differentiation.<br />Methods: Using cell-based assays and transcriptome and proteome data, the authors compared MSC cultures simultaneously grown under a conventional 19.95% O <subscript>2</subscript> atmosphere or at 5% O <subscript>2</subscript> .<br />Results: In 5% O <subscript>2</subscript> , MSCs showed better proliferation and higher self-renewal ability, most probably sustained by enhanced signaling activity of mitogen-activated protein kinase and mammalian target of rapamycin pathways. Non-oxidative glycolysis-based energy metabolism supported growth and proliferation in 5% O <subscript>2</subscript> cultures, whereas MSCs grown under 19.95% O <subscript>2</subscript> also utilized oxidative phosphorylation. Cytoprotection mechanisms used by cells under 5% O <subscript> <subscript>2</subscript> </subscript>  differed from 19.95% O <subscript> <subscript>2</subscript> </subscript>   suggesting differences in the triggers of cell stress between these two O <subscript> <subscript>2</subscript> </subscript>   conditions.<br />Conclusions: Based on the potential benefits for the growth and metabolism of MSCs, the authors propose the use of 5% O <subscript>2</subscript> for MSC culture.<br /> (Copyright © 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1477-2566
- Volume :
- 24
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Cytotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 36109320
- Full Text :
- https://doi.org/10.1016/j.jcyt.2022.06.005